{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:06:50Z","timestamp":1786990010201,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.healun.2017.03.013","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T13:03:14Z","timestamp":1490360594000},"page":"441-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation"],"prefix":"10.1016","volume":"37","author":[{"given":"Christopher S.","family":"Almond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chesney","family":"Castleberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin K.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie D.","family":"Everitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfriede","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pruitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doff B.","family":"McElhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2017.03.013_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCOUTCOMES.113.000149","article-title":"Informed choice of composite end points in cardiovascular trials","volume":"7","author":"Gomez","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.healun.2017.03.013_bib2","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/sim.6205","article-title":"Use of composite endpoints in clinical trials","volume":"33","author":"Sankoh","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.healun.2017.03.013_bib3","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1161\/STROKEAHA.107.509893","article-title":"Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published trials","volume":"39","author":"Bath","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.healun.2017.03.013_bib4","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/cc10240","article-title":"The added value of ordinal analysis in clinical trials: an example in traumatic brain injury","volume":"15","author":"Roozenbeek","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.healun.2017.03.013_bib5","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/sim.4780122404","article-title":"Sample size calculations for ordered categorical data","volume":"12","author":"Whitehead","year":"1993","journal-title":"Stat Med"},{"key":"10.1016\/j.healun.2017.03.013_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.healun.2017.03.013_bib7","first-page":"II69","article-title":"Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience","volume":"94","author":"Shaddy","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.03.013_bib8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1600-6143.2011.03932.x","article-title":"A risk-prediction model for in-hospital mortality after heart transplantation in US children","volume":"12","author":"Almond","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2017.03.013_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","volume":"111","author":"Hogg","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.healun.2017.03.013_bib15","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2017.03.013_bib16","series-title":"Post-transplant lymphoproliferative disorders","article-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.healun.2017.03.013_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2010.08.031","article-title":"Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study","volume":"30","author":"Everitt","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib18","series-title":"Statistical analysis with missing data","author":"Little","year":"2014"},{"key":"10.1016\/j.healun.2017.03.013_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/biomet\/92.4.965","article-title":"Concordance probability and discriminatory power in proportional hazards regression","volume":"92","author":"Gonen","year":"2005","journal-title":"Biometrica"},{"key":"10.1016\/j.healun.2017.03.013_bib20","series-title":"Missing data","first-page":"136","author":"Allison","year":"2001"},{"key":"10.1016\/j.healun.2017.03.013_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.healun.2017.03.013_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2015.05.063","article-title":"Improved detection of cardiac allograft vasculopathy: a multi-institutional analysis of functional parameters in pediatric heart transplant recipients","volume":"66","author":"Kindel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.03.013_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.healun.2004.03.021","article-title":"The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study","volume":"24","author":"Pahl","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1053-2498(03)00059-7","article-title":"Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience","volume":"23","author":"Chin","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.healun.2013.08.005","article-title":"The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric heart transplantation report\u20142013; Focus theme: age","volume":"32","author":"Dipchand","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2017.03.013_bib27","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.healun.2010.01.013","article-title":"Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients","volume":"29","author":"Manlhiot","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.96.1.227","article-title":"Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study","volume":"96","author":"Canter","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.03.013_bib29","first-page":"1207","article-title":"Infection after pediatric heart transplantation: results of a multiinstitutional study","volume":"16","author":"Schowengerdt","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jtcvs.2007.09.019","article-title":"Predicting survival among high-risk pediatric cardiac transplant recipients: an analysis of the United Network for Organ Sharing database","volume":"135","author":"Davies","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.03.013_bib31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1161\/CIRCULATIONAHA.114.009120","article-title":"Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database","volume":"131","author":"Schumacher","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.03.013_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.03.013_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1399-3046.2005.00296.x","article-title":"A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation","volume":"9","author":"Benfield","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib34","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1600-6143.2012.04145.x","article-title":"Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up","volume":"12","author":"Sarwal","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007890-200001150-00016","article-title":"NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation","volume":"69","author":"Alvarez","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2017.03.013_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","article-title":"Enalapril in infants with single ventricle: results of a multicenter randomized trial","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.03.013_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2011.01.061","article-title":"A multicenter, randomized trial comparing heparin\/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children","volume":"58","author":"Monagle","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.03.013_bib38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2017.03.013_bib39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jacc.2011.01.062","article-title":"Preventing thrombosis after the Fontan procedure not there yet","volume":"58","author":"Canter","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.03.013_bib40","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jama.298.10.1214","article-title":"The importance of randomized controlled trials in pediatric cardiology","volume":"298","author":"Gidding","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2017.03.013_bib41","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1161\/CIRCULATIONAHA.110.989897","article-title":"Letter by Singh regarding article, \"Enalapril in infants with single ventricle: results of a multicenter randomized trial.\"","volume":"123","author":"Singh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.03.013_bib42","unstructured":"U.S. Food and Drug Administration. Biomarkers and surrogate endpoints. July 2015. http:\/\/www.fda.gov\/downloads\/NewsEvents\/Newsroom\/FactSheets\/UCM455106.pdf\/. Accessed November 28, 2015."},{"key":"10.1016\/j.healun.2017.03.013_bib43","unstructured":"U.S. Food and Drug Administration. FDA Guidance for Industry: providing clinical evidence of effectiveness for human drug and biological products. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). 1998. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceCompliance%20RegulatoryInformation\/Guidances\/UCM078749.pdf+Providing+clinical+evidence+of+effectiveness+for+human+and+bio&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&ie=UTF-8&access=p&oe=UTF-8. Accessed September 15, 2015."},{"key":"10.1016\/j.healun.2017.03.013_bib44","unstructured":"U.S. Food and Drug Administration. Workshop: surrogate endpoints for clinical trials in kidney transplantation; public workshop. September 28, 2015. https:\/\/www.fda.gov\/Drugs\/NewsEvents\/ucm449248.htm. Accessed November 28, 2015."},{"key":"10.1016\/j.healun.2017.03.013_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2017.03.013_bib46","unstructured":"U.S. Food and Drug Administration. FDA Guidance for Industry: Clinical trial endpoints for the approval of cancer drugs and biologics. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). 2007. https:\/\/www.fda.gov\/downloads\/drugsGuidanceComplianceRegulatoyInformation\/Guidance\/UCM071590.pdf. Accessed April 25, 2017."}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324981731728X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324981731728X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:34:36Z","timestamp":1760949276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324981731728X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S105324981731728X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2017.03.013","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2017.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of International Society for the Heart and Lung Transplantation","name":"copyright","label":"Copyright"}]}}